Kim-Hafken Tina
Algemeen Adviseur bij RAIN ONCOLOGY INC.
Profiel
Kim-Hafken Tina is currently working as Vice President-Regulatory Affairs at Rain Oncology, Inc. Previously, she worked as Senior Director-Regulatory Affairs at Seagen Inc. She completed her undergraduate degree from The Johns Hopkins University and the University of Kansas.
Actieve functies van Kim-Hafken Tina
| Bedrijven | Functie | Begin |
|---|---|---|
| RAIN ONCOLOGY INC. | Algemeen Adviseur | - |
Eerdere bekende functies van Kim-Hafken Tina
| Bedrijven | Functie | Einde |
|---|---|---|
| SEAGEN INC. | Algemeen Adviseur | - |
Opleiding van Kim-Hafken Tina
| The Johns Hopkins University | Undergraduate Degree |
| University of Kansas | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Rain Oncology, Inc.
 Rain Oncology, Inc. BiotechnologyHealth Technology Rain Oncology, Inc. is a clinical-stage precision oncology company, which focuses on developing and implement the precision oncology therapies for patients suffering from cancer. The company was founded by Avanish Vellanki and Robert Doebele in April 2017 and is headquartered in Newark, CA. | Health Technology |
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
